5 Results for "

malaria schizonts

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "malaria schizonts" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-12784A
CAS No.: 152-53-4
Purity:  99.93%
Synonyms: Chlorguanide triazine hydrochloride
Research Areas:  

Infection Cancer

Cycloguanil (Chlorguanide triazine) hydrochloride is a dihydrofolate reductase (DHFR) inhibitor with an IC50 of 10.8 μM against human DHFR. Cycloguanil hydrochloride blocks the folate metabolic pathway, thereby affecting nucleotide synthesis and interfering with DNA replication. Cycloguanil inhibits DHFR in Plasmodium and is thus used in malaria research. Cycloguanil hydrochloride also potently inhibits DHFR in human cancer cells and blocks the transcriptional activity of STAT3, thereby exhibiting anticancer activity .
loading...
    loading...
Cat. No.: HY-117015
CAS No.: 1038620-68-6
Purity:  99.44%
Target:  

Parasite

Research Areas:  

Infection

Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM. Purfalcamine has antimalarial activity and causes malaria parasites developmental arrest at the schizont stage .
loading...
    loading...
Cat. No.: HY-12784
CAS No.: 516-21-2
Synonyms: Chlorguanide triazine
Research Areas:  

Infection Cancer

Cycloguanil (Chlorguanide triazine) is a dihydrofolate reductase (DHFR) inhibitor with an IC50 of 10.8 μM against human DHFR. Cycloguanil blocks the folate metabolic pathway, thereby affecting nucleotide synthesis and interfering with DNA replication. Cycloguanil inhibits DHFR in Plasmodium and is thus used in malaria research. Cycloguanil also potently inhibits DHFR in human cancer cells and blocks the transcriptional activity of STAT3, thereby exhibiting anticancer activity .
loading...
    loading...
Cat. No.: HY-18746
CAS No.: 1513879-18-9
Target:  

Parasite PI4K

Research Areas:  

Infection

KAI-407 is an orally active inhibitor of Plasmodium PI4K kinase, which can broadly inhibit multiple stages of the parasite lifecycle. KAI-407 exhibits EC50s of for the blood stage of malignant Plasmodium of 81 nM; for the liver schizonts of P. yoelii of 88 nM; and IC50s for the liver schizonts and dormant bodies of P. cynomolgi of 0.64 μM and 0.69 μM respectively. KAI-407 can prevent Plasmodium berghei infection 100%. KAI-407 can be used for the study of vivax malaria .
loading...
    loading...
Cat. No.: HY-184395
Target:  

Parasite

Research Areas:  

Infection

HLQ-102 is an orally active parasite cytochrome bc1 complex Qi site binder. HLQ-102 inhibits the growth of Plasmodium. HLQ-102 exhibits antimalarial activity against Plasmodium in mice. HLQ-102 can be used in malaria-related research .
loading...
    loading...